Arbe Robotics reported a third-quarter loss of $0.07 per share, narrower than the $0.10 loss a year earlier. Revenue nearly tripled, rising 196.1% to $0.75 million. No consensus estimate was available, so the quarter cannot be scored as a beat or miss. That matters less than the central tension in the report. Arbe announced the most important commercial validation in its history, a Level 3 passenger-vehicle program with one of the world's largest automotive groups. In the same release, it cut its 2026 revenue outlook roughly in half. The strategic story improved materially while the near-term financial story got worse.
The quality of the improvement deserves scrutiny. Operating expenses fell to $9.1 million from $11.3 million a year ago, and the GAAP net loss narrowed to $9.0 million from $11.0 million. A meaningful part of that savings came from lower share-based compensation, which dropped to $0.9 million from $2.0 million. R&D spending also fell to $6.6 million from $8.3 million. On a cash basis, the improvement is real. Operating cash burn fell to $7.8 million from $11.1 million, and the adjusted EBITDA loss narrowed to $8.0 million from $9.2 million. Gross profit reached roughly break-even after a loss a year ago. Still, revenue of $0.75 million against a $9 million quarterly expense base shows how far Arbe remains from self-funding. The weighted share count rose to 129.4 million from 112.6 million. The September $15 million offering, which netted $13.8 million, was the company's second equity raise of 2026.
The guidance revision is the clearest negative. Full-year revenue guidance fell to $2.3 million to $3.0 million from $4 million to $6 million. That earlier range had been set in February and reaffirmed after both the first and second quarters. Management attributed the cut to two integration projects whose deliveries slipped from the fourth quarter into 2027. With $1.9 million booked through nine months, the new range implies fourth-quarter revenue of roughly $0.4 million to $1.1 million. That is not a step up from the third quarter. The adjusted EBITDA loss outlook widened to $34 million to $35 million from $28 million to $31 million. Management cited lower revenue and investment in a radar-system production line and inventory ahead of hoped-for 2027 order growth. Building inventory before orders materialize is a reasonable bet only if the pipeline converts.
That pipeline is where management's tone turned decidedly more confident. CEO Ram Machness called the third quarter "a turning point." Under the Level 3 program, Tier 1 Hirain's imaging radar, built on Arbe's chipset, was selected across multiple brands in China. Series deliveries are scheduled to begin in the fourth quarter of 2027. On the call, management guided to "a few millions" of related revenue in 2027, ramping through 2028-29. Defense moved quickly from selection to substance. A global defense integrator's three projects produced initial orders and deliveries, two more integration projects are underway, and more than eight are in early evaluation. The newly launched Alerion counter-drone radar targets a market management cited at about $30 billion by 2031. On the call, management also said a robotaxi customer is driving vehicles on US roads with 360-degree Arbe radar coverage and training its perception stack on Arbe data.
The risks are equally concrete. Meaningful automotive revenue remains about a year away and depends on Hirain executing to production. Defense programs carry shorter sales cycles, as management emphasized, but the guidance cut itself shows that project timing can move against the company. The finance function also changed hands, with Assaf Pereg becoming CFO at the end of August.
Liquidity is adequate but not abundant. Arbe ended the quarter with $48.0 million in cash and deposits and remains in compliance with its convertible-debenture covenants. However, $24.3 million of convertible bonds sit in current liabilities. At the implied fourth-quarter burn rate, the cushion covers roughly a year and a half of operations before any revenue ramp. The stock opened at $0.70 after the August report, just below its $0.75 200-day moving average. That sub-dollar valuation already reflects deep skepticism about whether design wins can turn into revenue before more dilution is required.
The bottom line is that Arbe's third quarter improved the long-term thesis while weakening the near-term one. The Level 3 win and early defense orders give the company a credible path to scaled revenue that it lacked a year ago. However, the guidance cut, the widening loss outlook, and continued reliance on equity funding mean investors are again being asked to wait until 2027. Converting defense interest and the delayed integration projects into recognized revenue in the next few quarters will be the test of whether this really was a turning point.